GARDASIL-9 Strain Vaccine
26,500 THB | Expiry Date 01 February 2027
Helping to protect against 9 high-risk and low-risk HPV types—the leading causes of cervical cancer and other HPV-related diseases.
GARDASIL-9 Vaccine: The Ultimate Shield Against HPV
HPV (Human Papillomavirus) is so common that nearly all sexually active men and women will get it at some point in their lives. GARDASIL-9 is the most advanced vaccine available to protect against this virus, offering broader coverage than any previous version.
By targeting nine specific strains of HPV, this vaccine serves as a powerful preventative tool against multiple types of cancer and genital warts for both men and women.
Why the “9” Matters
While earlier vaccines protected against 2 or 4 strains, GARDASIL-9 expands that protection significantly. It targets the HPV types (6, 11, 16, 18, 31, 33, 45, 52, and 58) responsible for:
~90% of Cervical Cancers
~90% of Genital Warts
~85% of Vaginal Cancers
Significant rates of Anal, Vulvar, and Throat (Oropharyngeal) Cancers
Who Should Get Vaccinated?
Protection is a priority for everyone, not just women.
Children & Adolescents (Ages 9–14):The immune response is strongest at this age. Requires only 2 doses.
Teens & Adults (Ages 15–45):Catch-up vaccination is highly recommended to protect against strains you haven’t been exposed to yet. Requires 3 doses.
Males: Vaccination prevents anal cancer, genital warts, and throat cancer, while also stopping the spread of the virus to partners.
Preventing the Preventable
Most HPV infections show no symptoms until they cause serious health problems. Vaccination is the only safe way to build immunity without facing the risks of infection.
Don’t wait for a diagnosis. Choose protection today.
Terms and Conditions
1.The package includes doctor’s fees and hospital service charges.
2.This package is valid until 1 February 2027.
3.Location: Women’s Center, 12th Floor, Building B, Phyathai 2 Hospital.
4.Prices are for financial planning purposes only and are subject to change without prior notice.